Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

Joseph Ciccolini; Cindy Serdjebi; Godefridus J. Peters; Elisa Giovannetti

doi:10.1007/s00280-016-3003-0

Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

Joseph Ciccolini, Cindy Serdjebi, Godefridus J. Peters, Elisa Giovannetti

Medical oncology laboratory

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1-12
Journal	Cancer Chemotherapy and Pharmacology
Volume	78
Issue number	1
DOIs	https://doi.org/10.1007/s00280-016-3003-0
Publication status	Published - Jul 2016

Cite this

Ciccolini, J., Serdjebi, C., Peters, G. J., & Giovannetti, E. (2016). Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective. Cancer Chemotherapy and Pharmacology, 78(1), 1-12. https://doi.org/10.1007/s00280-016-3003-0

@article{1298566c3bca43dfa33ad3478ea5dfe8,

title = "Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective",

keywords = "Gemcitabine, 2 ',2 '-difluoro-2 '-deoxyuridine, Cytidine deaminase, Polymorphisms, Pharmacogenetics, Gemcitabine prodrugs",

author = "Joseph Ciccolini and Cindy Serdjebi and Peters, {Godefridus J.} and Elisa Giovannetti",

year = "2016",

month = "7",

doi = "10.1007/s00280-016-3003-0",

language = "English",

volume = "78",

pages = "1--12",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

AU - Ciccolini, Joseph

AU - Serdjebi, Cindy

AU - Peters, Godefridus J.

AU - Giovannetti, Elisa

PY - 2016/7

Y1 - 2016/7

KW - Gemcitabine

KW - 2 ',2 '-difluoro-2 '-deoxyuridine

KW - Cytidine deaminase

KW - Polymorphisms

KW - Pharmacogenetics

KW - Gemcitabine prodrugs

U2 - 10.1007/s00280-016-3003-0

DO - 10.1007/s00280-016-3003-0

M3 - Article

C2 - 27007129

VL - 78

SP - 1

EP - 12

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 1

ER -

Access to Document

10.1007/s00280-016-3003-0